Overview

Beta Cell Restoration Through Fat Mitigation

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.
Phase:
N/A
Details
Lead Sponsor:
University of Southern California
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Metformin